Lv3
326 积分 2023-09-21 加入
First-in-Human, Phase Ia, Dose Escalation, Monotherapy Study of QLS32015, a Novel GPRC5D×CD3 T-Cell Engaging Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
3天前
求助中
An Uniquely Designed Asymmetric Bispecific Antibody Against GPRC5D and CD3 (LBL-034) in Patients with Relapsed/Refractory Multiple Myeloma: A Phase I/II, First in Human, Open-Label, Multicenter, Dose Escalation/Expansion Study
3天前
求助中
Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions
4天前
已完结
Targeting GPRC5D in multiple myeloma
7天前
已完结
Weighted gene co-expression network analysis and single-cell sequence analysis uncover immune landscape and reveal hub genes of necroptosis in macrophages in myocardial ischaemia–reperfusion injury
12天前
已完结
Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia
20天前
已完结
Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anemia in Children and Young Adults: A Report from the Pediatric Severe Aplastic Anemia Consortium of India
20天前
已完结
Targeting GPRC5D in multiple myeloma
23天前
已完结
Neue Daten zur Therapie des multiplen Myeloms, Hodgkin-Lymphoms, DLBCL und MDS
1个月前
已完结
Addition of elotuzumab to backbone treatment regimens for multiple myeloma: an updated meta-analysis of randomized clinical trials
1个月前
已完结
皖公网安备34019202002308
